Teladoc Health, Inc. - Understand $tdoc stock

$TDOC Market Cap: $1.897 Billion

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$2.590B

TTM

Gross Margin

70.82%

TTM

Net Earnings

-$981.7M

TTM

Current Assets

$1.609B

Q3 2024

Current Liabilities

$931.4M

Q3 2024

Current Ratio

172.72%

Q3 2024

Total Assets

$3.529B

Q3 2024

Total Liabilities

$2.021B

Q3 2024

Book Value

$1.508B

Q3 2024

Cash

$1.244B

Q3 2024

P/E

-1.933

Nov 29, 2024 EST

Free Cash Flow

$241.3M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	$2.602B	$2.407B	$2.033B	$1.094B	$553.3M	$417.9M	$233.3M	$123.2M	$77.40M	$43.50M	$19.90M
YoY Change	8.13%	18.41%	85.81%	97.71%	32.4%	79.14%	89.35%	59.17%	77.93%	118.59%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	$2.602B	$2.407B	$2.033B	$1.094B	$553.3M	$417.9M	$233.3M	$123.2M	$77.40M	$43.50M	$19.90M
Cost Of Revenue	$760.0M	$744.0M	$650.3M	$390.8M	$184.5M	$128.7M	$61.62M	$32.00M	$21.00M	$9.900M	$4.200M
Gross Profit	$1.842B	$1.663B	$1.382B	$703.1M	$368.8M	$289.2M	$171.7M	$91.20M	$56.30M	$33.60M	$15.70M
Gross Profit Margin	70.8%	69.09%	68.01%	64.27%	66.66%	69.2%	73.58%	74.03%	72.74%	77.24%	78.89%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Selling, General & Admin	$678.4M	$677.0M	$688.6M	$660.7M	$229.4M	$176.1M	$117.8M	$116.8M	$93.10M	$38.90M	$17.30M
YoY Change	0.21%	-1.68%	4.22%	188.06%	30.27%	49.51%	0.83%	25.46%	139.33%	124.86%
% of Gross Profit	36.82%	40.71%	49.81%	93.97%	62.19%	60.89%	68.61%	128.07%	165.36%	115.77%	110.19%
Research & Development	$348.5M	$333.6M	$311.9M	$164.9M	$64.64M	$54.37M	$34.46M	$21.80M	$14.20M	$7.600M	$3.500M
YoY Change	4.46%	6.97%	89.09%	155.15%	18.89%	57.79%	58.07%	53.52%	86.84%	117.14%
% of Gross Profit	18.92%	20.06%	22.56%	23.46%	17.53%	18.8%	20.07%	23.9%	25.22%	22.62%	22.29%
Depreciation & Amortization	$339.7M	$256.0M	$204.2M	$69.50M	$38.95M	$35.60M	$19.10M	$8.270M	$4.860M	$2.320M	$750.0K
YoY Change	32.67%	25.36%	193.89%	78.41%	9.41%	86.45%	130.89%	70.16%	109.48%	209.33%
% of Gross Profit	18.44%	15.4%	14.77%	9.88%	10.56%	12.31%	11.12%	9.07%	8.63%	6.9%	4.78%
Operating Expenses	$1.027B	$1.011B	$1.000B	$825.7M	$294.0M	$230.4M	$152.2M	$146.9M	$112.2M	$48.80M	$21.60M
YoY Change	1.61%	1.02%	21.17%	180.83%	27.59%	51.38%	3.62%	30.93%	129.92%	125.93%
Operating Profit	-$248.6M	-$13.65B	-$265.6M	-$506.4M	-$80.44M	-$70.85M	-$75.39M	-$55.70M	-$55.90M	-$15.20M	-$5.900M
YoY Change	-98.18%	5039.92%	-47.55%	529.55%	13.53%	-6.02%	35.36%	-0.36%	267.76%	157.63%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Interest Expense	$22.28M	-$9.270M	-$80.37M	-$60.50M	-$29.00M	-$26.10M	-$17.50M	-$2.600M	-$2.200M	-$1.500M	-$100.0K
YoY Change	-340.37%	-88.47%	32.83%	108.62%	11.11%	49.14%	573.08%	18.18%	46.67%	1400.0%
% of Operating Profit
Other Income/Expense, Net	$4.445M	-$859.0K	$5.088M	-$545.0K	$342.0K
YoY Change	-617.46%	-116.88%	-1033.58%	-259.36%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Pretax Income	-$219.6M	-$13.66B	-$384.7M	-$576.0M	-$109.5M	-$96.97M	-$107.0M	-$73.70M	-$58.00M	-$16.60M	-$5.900M
YoY Change	-98.39%	3452.09%	-33.22%	426.24%	12.88%	-9.38%	45.19%	27.07%	249.4%	181.36%
Income Tax	$760.0K	-$3.812M	$44.14M	-$90.86M	-$10.59M	$118.0K	-$225.0K	$500.0K	$0.00	$400.0K	$100.0K
% Of Pretax Income
Net Earnings	-$220.4M	-$13.66B	-$428.8M	-$485.1M	-$98.86M	-$97.08M	-$106.8M	-$74.20M	-$58.00M	-$17.00M	-$6.000M
YoY Change	-98.39%	3085.58%	-11.61%	390.71%	1.83%	-9.08%	43.91%	27.93%	241.18%	183.33%
Net Earnings / Revenue	-8.47%	-567.53%	-21.09%	-44.35%	-17.87%	-23.23%	-45.77%	-60.23%	-74.94%	-39.08%	-30.15%
Basic Earnings Per Share	-$1.34	-$84.60	-$2.73	-$5.36	-$1.38
Diluted Earnings Per Share	-$1.34	-$84.60	-$2.73	-$5.36	-$1.38	-$1.476M	-$1.928M	-$1.754M	-$2.915M	-$8.500M	-$5.000M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Cash & Short-Term Investments	$1.124B	$918.2M	$896.0M	$787.0M	$517.0M	$479.0M	$122.0M	$66.00M	$137.0M	$46.00M	$3.000M
YoY Change	22.38%	2.47%	13.85%	52.22%	7.93%	292.62%	84.85%	-51.82%	197.83%	1433.33%
Cash & Equivalents	$1.124B	$918.2M	$893.5M	$733.0M	$514.0M	$424.0M	$43.00M	$50.00M	$55.00M	$46.00M	$3.000M
Short-Term Investments		$0.00	$2.537M	$53.00M	$3.000M	$55.00M	$79.00M	$16.00M	$82.00M	$0.00
Other Short-Term Assets	$118.4M	$105.2M	$87.39M	$47.00M	$14.00M	$11.00M	$7.000M	$3.000M	$2.000M	$1.000M	$1.000M
YoY Change	12.56%	20.41%	85.93%	235.71%	27.27%	57.14%	133.33%	50.0%	100.0%	0.0%
Inventory	$29.51M	$56.34M	$73.08M	$56.00M
Prepaid Expenses
Receivables	$217.4M	$210.6M	$169.0M	$169.0M	$57.00M	$44.00M	$27.00M	$14.00M	$12.00M	$7.000M	$3.000M
Other Receivables	$0.00	$25.09M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.489B	$1.315B	$1.225B	$1.060B	$588.0M	$533.0M	$156.0M	$83.00M	$152.0M	$54.00M	$7.000M
YoY Change	13.2%	7.34%	15.61%	80.27%	10.32%	241.67%	87.95%	-45.39%	181.48%	671.43%
Property, Plant & Equipment	$72.09M	$71.47M	$74.01M	$75.00M	$37.00M	$10.00M	$9.000M	$7.000M	$6.000M	$1.000M	$0.00
YoY Change	0.87%	-3.43%	-1.31%	102.7%	270.0%	11.11%	28.57%	16.67%	500.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$80.26M	$48.54M	$20.70M	$18.00M	$7.000M	$1.000M	$1.000M	$0.00	$0.00	$0.00	$0.00
YoY Change	65.34%	134.46%	15.02%	157.14%	600.0%	0.0%
Total Long-Term Assets	$2.903B	$3.030B	$16.51B	$16.70B	$1.015B	$996.0M	$668.0M	$221.0M	$78.00M	$38.00M	$20.00M
YoY Change	-4.18%	-81.65%	-1.11%	1544.83%	1.91%	49.1%	202.26%	183.33%	105.26%	90.0%
Total Assets	$4.392B	$4.345B	$17.73B	$17.76B	$1.603B	$1.529B	$824.0M	$304.0M	$230.0M	$92.00M	$27.00M
YoY Change
Accounts Payable	$43.64M	$47.69M	$47.26M	$46.00M	$9.000M	$8.000M	$4.000M	$2.000M	$2.000M	$2.000M	$0.00
YoY Change	-8.5%	0.92%	2.73%	411.11%	12.5%	100.0%	100.0%	0.0%	0.0%
Accrued Expenses	$281.3M	$193.4M	$162.0M	$156.0M	$58.00M	$41.00M	$27.00M	$13.00M	$11.00M	$6.000M	$2.000M
YoY Change	45.43%	19.4%	3.85%	168.97%	41.46%	51.85%	107.69%	18.18%	83.33%	200.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$11.38M	$13.31M	$56.00M			$0.00	$2.000M	$1.000M	$1.000M	$0.00
YoY Change		-14.56%	-76.23%				-100.0%	100.0%	0.0%
Total Short-Term Liabilities	$420.6M	$399.8M	$331.0M	$333.0M	$90.00M	$62.00M	$40.00M	$21.00M	$18.00M	$10.00M	$5.000M
YoY Change	5.21%	20.77%	-0.6%	270.0%	45.16%	55.0%	90.48%	16.67%	80.0%	100.0%
Long-Term Debt	$1.539B	$1.543B	$1.235B	$1.390B	$440.0M	$415.0M	$207.0M	$42.00M	$25.00M	$25.00M	$3.000M
YoY Change	-0.3%	24.97%	-11.15%	215.91%	6.02%	100.48%	392.86%	68.0%	0.0%	733.33%
Other Long-Term Liabilities	$57.54M	$43.53M	$47.10M	$47.00M	$37.00M	$6.000M	$5.000M	$8.000M	$7.000M	$3.000M	$0.00
YoY Change	32.18%	-7.57%	0.21%	27.03%	516.67%	20.0%	-37.5%	14.29%	133.33%
Total Long-Term Liabilities	$1.596B	$1.587B	$1.282B	$1.437B	$477.0M	$421.0M	$212.0M	$50.00M	$32.00M	$28.00M	$3.000M
YoY Change	0.59%	23.78%	-10.78%	201.26%	13.3%	98.58%	324.0%	56.25%	14.29%	833.33%
Total Liabilities	$2.066B	$2.038B	$1.689B	$1.871B	$589.0M	$516.0M	$265.0M	$73.00M	$51.00M	$39.00M	$8.000M
YoY Change	1.41%	20.65%	-9.74%	217.66%	14.15%	94.72%	263.01%	43.14%	30.77%	387.5%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020	2019
Basic Shares Outstanding	164.6M shares	161.5M	156.9M	90.51M	71.85M
Diluted Shares Outstanding	164.6M shares	161.5M	156.9M	90.51M	71.85M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $1.8973 Billion

About Teladoc Health, Inc.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. The company is headquartered in Purchase, New York and currently employs 5,600 full-time employees. The company went IPO on 2015-07-01. The firm operates through two segments: Teladoc Health Integrated Care (Integrated Care) and BetterHelp. The Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed primarily on a business-to-business (B2B) basis. The BetterHelp segment primarily consists of its direct-to-consumer (D2C) mental health platform. The online counseling and therapy services are provided via its network of over 40,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs.

Industry: Services-Offices & Clinics of Doctors of Medicine Peers: Certara, Inc. Change Healthcare Inc. Definitive Healthcare Corp. Doximity, Inc. Evolent Health, Inc. VEEVA SYSTEMS INC